Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Next Science jumps almost 10pc after XPERIENCE study published in science journal
Health & Biotech
ASX Health Stocks: Island Pharma advances anti-viral study; Compumedics scores $9.3m order in China
Health & Biotech
“Market is going to be surprised” as Firebrick Pharma set to launch antiviral nasal spray, Nasodine
Health & Biotech
ASX Health Stocks: Clarity Pharma, Island Pharma set to embark on next steps of clinical trials
Health & Biotech
ASX Health Stocks: Island Pharma granted Aussie patent for flavivirus infection drug, ISLA-101
Health & Biotech
ASX Health Stocks: Starpharma jumps 30pc after cancer drug helps enable ‘100 per cent’ control rate
Health & Biotech
ASX Health Stocks: AdAlta jumps 40pc after its fibrosis drug shows ‘potential efficacy’ in humans
Health & Biotech
The Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreak
Health & Biotech
Which ASX stocks are on the path from FDA to clinical trial in 2023?
Health & Biotech
ASX Tech & Biotech: Island Pharma files investigational application for new Dengue Fever drug
Health & Biotech
ASX Health Stocks: Rhythm Bio taps Baker Institute as partner; Island Pharma gets ethics approval in US
Health & Biotech
ASX Health Stocks: New patent for Island Pharma in Canada; Nova Eye beats sales guidance
Health & Biotech
ASX Health Stocks: EMV jumps 7pc after delivering portable brain scanner; Firebrick gets Aussie patent
Health & Biotech
ASX Health Stocks: Neuroscientific says EmtinB shows positive signs, expects full results in H2
Escrow Watch
Escrow Watch: Which companies have shares coming out of escrow in April?
Health & Biotech
